Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01993238 · ClinicalTrials.gov registry record · NA
Evaluation of Procedural Analgesia for Liposonix Treatment
A NA study of Body Contouring, sponsored by Solta Medical.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT01993238: Completed NA study of Body Contouring, sponsored by Solta Medical.
NCT01993238 is a NA study of Body Contouring that has completed, run by Solta Medical. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01993238, a NA study of Body Contouring, has completed, sponsored by Solta Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The objectives of this study are to evaluate the safety and effectiveness of procedural analgesia for improvements in tolerability of treatment with the Liposonix System.
Primary Outcome
Following treatment, the subject was asked to evaluate the pain level for the overall treatment using the 0-10 Visual Analog Scale (0 represents no pain and 10 represents worst imaginable pain)
Conditions Studied
Interventions
- DEVICE Liposonix System (Model 2)
- DRUG Pre-treatment analgesia
Study Locations (1)
California
- Solta Medical Aesthetic Center - Hayward
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-01 |
| Phase | NA |
What the finished NCT01993238 record still lists
NCT01993238 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Body Contouring appearing as the primary indexed condition, and to 2 interventions - of which Liposonix System (Model 2) is the first listed.
NCT01993238 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01993238 about?
NCT01993238 is a clinical study titled "Evaluation of Procedural Analgesia for Liposonix Treatment". The objectives of this study are to evaluate the safety and effectiveness of procedural analgesia for improvements in tolerability of treatment with the Liposonix System.
What is the current status of trial NCT01993238?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2013-11. Estimated completion is 2014-01.
What conditions does trial NCT01993238 study?
This clinical trial studies the following conditions: Body Contouring.
What interventions are being tested in trial NCT01993238?
The interventions under investigation include: Liposonix System (Model 2) (DEVICE), Pre-treatment analgesia (DRUG).
Who is sponsoring clinical trial NCT01993238?
This trial is sponsored by Solta Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01993238 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Body Contouring
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01993238's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia